These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23678537)

  • 1. The antibody race.
    von Bubnoff A
    IAVI Rep; 2013; 17(1):12-5, 19. PubMed ID: 23678537
    [No Abstract]   [Full Text] [Related]  

  • 2. Current world literature.
    Curr Opin HIV AIDS; 2009 Sep; 4(5):453-7. PubMed ID: 20046137
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel adjuvants for B cell immune responses.
    Loré K; Karlsson Hedestam GB
    Curr Opin HIV AIDS; 2009 Sep; 4(5):441-6. PubMed ID: 20048709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines to antibodies: grow up!
    von Bubnoff A
    IAVI Rep; 2010; 14(4):4-9. PubMed ID: 20857647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2017 Keystone Symposium on HIV Vaccines.
    Cottrell CA; Ward AB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2348-2351. PubMed ID: 28786733
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV vaccine development--improving on natural immunity.
    Johnston MI; Fauci AS
    N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS research. Novel antibody response may explain HIV vaccine success.
    Cohen J
    Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167
    [No Abstract]   [Full Text] [Related]  

  • 8. As antibody findings mount, what comes next? Interview by Kristen Jill Kresge and Regina McEnery.
    Burton D; Mascola J; Michael N; Overbaugh J
    IAVI Rep; 2011; 15(1):4-7. PubMed ID: 21449503
    [No Abstract]   [Full Text] [Related]  

  • 9. Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV.
    Ali Tabei SM; Li Y; Weigert M; Dinner AR
    Vaccine; 2012 Jan; 30(3):607-13. PubMed ID: 22119591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.
    Parsons MS; Rouleau D; Routy JP; LeBlanc R; Grant MD; Bernard NF
    AIDS; 2011 Jun; 25(10):1249-64. PubMed ID: 21516028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious disease. An enterprising time for HIV vaccine research.
    Cohen J
    Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
    Ross AL; Bråve A; Scarlatti G; Manrique A; Buonaguro L
    Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RV144: old vs. new.
    Weiner DB
    Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV: Sequential vaccine elicits broadly neutralizing antibodies.
    Flemming A
    Nat Rev Drug Discov; 2016 Nov; 15(11):748-749. PubMed ID: 27807354
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Girard MP; Le-Grand R; Picot V; Longuet C; Nabel GJ
    Vaccine; 2016 Jun; 34(31):3557-61. PubMed ID: 27216761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RV144 Thai HIV vaccine trial.
    Plotkin SA
    Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
    Koff WC
    Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly neutralizing antibodies against HIV-1: templates for a vaccine.
    van Gils MJ; Sanders RW
    Virology; 2013 Jan; 435(1):46-56. PubMed ID: 23217615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliciting broad neutralizing antibody to HIV-1: envelopes of different lentivirus cross immunization by prime-boost vaccination.
    Luo Z; Ren L; Zheng Y; Qi Z; Liang H; Liu Y; Hong K; Shao Y
    Vaccine; 2012 Aug; 30(36):5316-23. PubMed ID: 22749599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS/HIV. A boost for HIV vaccine design.
    Burton DR; Weiss RA
    Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.